The use of tar and ultraviolet light as an inpatient therapy for psoriasis was described by Goeckerman more than 50 yr ago. Since that time it has been shown . to be an effective treatment for psoriasis at numerous medical centers with the average period of hospitalization approximating 3 weeks. This study was designed to evaluate whether inpatient treatment would be comprised ifthe patients were permitted to spend each night of the final week of treatment at home.
Of 267 patients hospitalized in 1979 for Goeckerman therapy, 84 patients were selected for study. These were divided into two groups, A and B. Group A consisted of patients receiving 3 weeks of inpatient care. Group B consisted of patients receiving 2 weeks hospitalization for inpatient Goeckerman therapy and 1 week of daily Goeckerman therapy in the ambulatory Psoriasis Treatment Center while spending the previous evening at home.
Group ' A and group B were compared for rate a nd degree of improvement and for duration of remission following hospital discharge. For purposes of statistical comparisons, patients from groups A and B were matched by sex, age, and date of admission to the study.
Both groups showed 80-90% c learing in the first 3 weeks. For patients in group A, the average total radiation received was 61.3 J/sq cm ofUVA and 9.85 J/sq cm of UVB. The average total radiation received by group B was 61.3 J/sq cm of UVA and 8.63 J/sq cm of UVB. Neither difference was statistically s ignificant (p < 0.50).
Both Group A and group B had similar numbers of patients who exacerbations required readmission to the hospital for either repeat Goeckerman therapy or for other types of treatment during the 18 mo follow-up period. The length of time before rehospitalization was also similar for both groups.
These findings are of a preliminary nature. However, it appears that the rate of clearing and period without exacerbation in psoriasis can be maintained by modifying the traditional inpatient Goeckerman regimen.
Fifty-five years ago Goeckerman reported the t herapeutic benefits of tar and ultraviolet light for the treatment of psoriasis. These original cases were all patients hospitalized at the Mayo Clinic [1] . The regimen consisted of (1) Today, controversy still exists as to the relative importance of the various components of the Goeckerman t h erapy; the most effective wavelengths of ultraviolet light and t he ideal tar preparation continue to be debated [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . However, t here is widespread concensus concerning the efficacy of Goeckerman's hospital program [2, 6, 9, 10, 14, 16, 18, [19] [20] [21] [22] .
In part because of t his controversy, a long-term, prospective study h as been undertaken to follow the course of 280 patients admitted to the Columbia-Presbyterian Medical Center in 1979. Particu lar emphasis was placed on evaluating the clincial response of t heir psoriasis to th e 3 modifications: (1) a more esthetic tar preparation, (2) th e use of quantitative amounts of ultraviolet radiation type A and B based on the patient's skin type and (3) the reduction of h ospital stay by administering the final portion of t he Goeckennan therapy in an ambulatory day care center designed to provide hospital level care.
MATERIALS AND METHODS
The patients in this study were chosen from those with severe plaque type psoriasis who were hospitalized at the Presbyterian Hospital between 1/1/ 79 and 12/31 / 79. The Goeckerman therapy used at th e Mayo Clinic in 1968, as described by Perry, Soderstrom,and Schulze [2] , was taken as the standard. Assessments were made concerning the rate of clinical "clearing," the length of hospital stay, and the duration of clinical rem ission. In addition, similar assessments were made of a subset of patients in a prospective, pilot study undertaken in cooperation with the New York and New J ersey Blue Cross Associations. This study is designed to evaluate the rate and extent of progress of patients who spent at least one-third of theil' treatment period in an ambu latol'y psoriasis treatment center. PATIENTS 280 psoriatic patients were admitted to the Presbyterian Hospital during this 12-mo study period. T hirteen patients had previously responded poorly to, or did not tolerate, the Goeckerman t herapy. T hey were treated with methotrexate (6 patients), pSOTalen and ultraviolet light (4 patients), or topical corticosteroids under occlusion (3 patients). These 13 patients have not been included in the following analysis.
The remaining 267 patients ( Gro up A-These patie nts r eceive d 3 weeks h ospitalization for inpatie nt Goecke rman therapy. Group B-These patie nts r eceived 2 weeks hospitalization for inpatie nt Goeckerma n t herapy a nd 1 wee k of d a ily Goeckerma n t h er apy in th e a mbulato ry P soriasis Treatment Cen ter while spending the evening at home. Grou p A a nd gr o up B were compared for rate a nd degree of improvemen t a nd for dmat io n of r e mission following hospital discharge. For pmposes of statistical compru'isons, patie nts from groups A a nd B were m atc h ed by sex, age, (within 5 yr) , a nd date of admissio n to t h e stud y (wit hin 1 m ol. Eighty -fom patients wer e ascertained who could be matched by th ese cri tel"ia (see Table II ).t They wer e di vided into 42 match ed pairs a nd evaluated for t h e length of stay required fo r " clearing." The m atc h ed pair va ria bles wer e designed to avoid errors arising fi'om differences in age, sex, a nd season of therapy. Therapy sch edu les for both gr o ups wer e s imilar a nd sh own in Table III a nd I V.
Light Source
Treatm e nt dming the inpa tie nt phase was d elivered fi'om specially designed phototherapy uni ts co ntaining fluorescent UV A and UVB t ubes arran ged to complet ely surround th e patient. The phototherapy uni t (Houva -Lite UVA / UVB Unit, Nationa l Biologics, C levela nd, OH) used in t h e h ospital contained 32 UVA t ubes (Houva-Lite S72T12 BL-HO) a nd 16 UVB tubes (HO-B-FS72-TI2B). The ligh t sOW'ce used for patients w ho receive d photother apy in th e a mbulatory psoriasis t reatment center (UV 8000 cabinet, Waldma nn Gmbh & Co., Schwe nninge n, W . Germa n y) co ntaine d 13 UVA tubes (Sylva nia FR90TI2-HO PUV A) a nd 27 UVB t ubes (Sylva nia F75/ 85-w UV-21) . The UVB flu or escent t ubes emi tted radiatio n prirnru'ily in t h e 285-350 nm range a nd UV A t ubes emitted radiation of 320-420 nm (Fig. 1 ) . UVA irradia nce was m easured daily with a n Inte rnatio nal Light IL400 Reseru'c h R a diometer using a calibrated SEE 400 detector (half-power points 270-540 run). UVB irradiance was measured m o nt hly us ing t he same radiome ter a nd a UVB fIl ter (half-power points 275-303 nm). To determine t h e total UVB (280-320 nm) ra di a tion, t he s pectral sensitivity of the d etector , a nd the e mission spectrum of the UVB flu or escent t ubes were correlated for compa rison with other standaJ"dized tubes. All m easurements were m a de with the sensor fas tened in the center of a n e mpty cabinet 50 em from a wall of bulbs to which it was directed . Exposme time based on il"radia n ce was calculate d daily.
t Of these, it was possible to collect data on 42 pairs for 6 mo, 36 pairs fo r 12 mo and 5 pairs for 18 mo. Data so ught was the length of time for readmission for hospital treatme nt of psoriasis and the time at which exacerbation of the psoriasis was noted. All statistical co mparisons b etween the 2 groups incorporated the matched pairing of patients. Differences between means were tested by the paired-sample t-test; differences between proportions were tested by an exact b"inomial test. " Out patients arrive at 8:30-9:00 AM and leave at 4:30-5:30 PM: both groups are exa mined, receive. calp treatments and indi vidua l instru ctions (group A) or co nferences (group B) da ily.
Topical Medications
The topical preparations used were compru'able for both gro up A a nd group B. T he use of topical corticoster oids was minimized exoept for lesions in volving t h e scalp , face, a nd in te rtriginous ar eas. Patients were instructed in t h e proper application of medications required for t he Goeckerm a n regimen a nd complia nce was monitor ed by nursing per sonnel.
T h e tar pre par ation used was a h ydro-alcoh olic gel (Estru' gel) conta ining a crude coal tru' extract rath er t ha n 5% crude co al tar o intme nt to t h e body twice daily. A m ajor reason for this m odification was t hat it was found to be m or e accepta ble est h etical.ly th a n c rude coal tru' for use by patients after h ospitalization. Tar was not used on the fa ce or intertriginous ru·eas. Bla nd e m ollie nts wer e applied as fre que ntly as needed to relieve dl"y ness. Each patient s pe nt 20 min in a tepid bath containing a tar and oil mixture (Balnatal' a nd Alpha K eri B ath Oil). A s uperfatted soap was used wh e n needed . In m a ny cases th e patie nts received a second tar bath in t h e afternoon. Salicyli c acid o intme nts were only used early in th e course of t herapy a nd discont inued whe n thick scales were removed.
Phototh erapy Sch edules
The skin type was used to determine each patient's initial a nd incre m e n tal phototherapy dosage of UVB a nd UV A (Ta ble III) . Each patient was classifie d into skin types based on many of t he criteria developed in th e cooperative trials of PUV A (psoralen a nd UV A therapy) [23] . Phototh erapy was administered 7 days each week. The daily dose of ultraviolet A a nd ultraviolet B were designed to elicit a non tender erythema of uninvolved skin. When tenderness and eryth ema occurred, phototherapy was deferred until t h e tenderness and erythema h ad abated. Identical phototherapy sch edules were used for group A and group B .
Clinical Severity and Response
The severity of each patient's psoriasis was described by estimating t h e percentage of body sUlface involved as well as the morphology of t h e lesions (Table V) ."Clearing" was considered t h e goal of therapy and was defined as the stage when more than 80% of th e initial lesions h ad no induration, scale, or eryth ema. These criteria applied to all of th e patients who were included in the study. Scalp lesions wer e excluded from the evalua tion of " clearing." Exacerbation was defined as the recurren ce of more than 25% of lesions excluding t hose of th e scalp. Observations and treatments were recorded on a standard flow sh eet. An attempt was made to examine or contact all patients 1, 3, 6, 8, 10, 12 and 18 mo following discharge as "cleared." ,
RESULTS
The average le ngth of h ospitalization for all 267 patients admitted to th e Presbyterian Hospital during 1979 for Goeckerman thera py using the tar gel a nd ultraviolet A + B was 20.0 days. The data for male patients was 19.6 days (range 4-40) and for female patients was 20.3 days (range 3-36). Comparison of the matched pai.rs of gro.up A and group B as indicated in Table VI showed the average length of hospitalization for both groups was n ot significantly different. Average total radiation r eceived by patients of each skin type is noted in Table VII . All m atc hed pairs were clear, as previously defined, at t h e time of discharge. For patients in group A, the average total radiation received was 61.3 J /sq. cm of UVA and 9.85 J /sq. cm of UVB . . The average total radiation received by group B was 61.3 J /sq. cm of UVA a nd 8.63 J /sq. cm of UVB. Neither differen ce was statistica lly significant (p > 0.50).
As note<:i in Fig 2 a nd 3 , both group A and group B h ad a similar number of patients whose exacerbations required readmission to the h ospital fo r either repeat Goeckerman th erapy or other types of treatment during the 18 rna follow-up period . The length of time before r eh ospitalization was also similar for both groups.
The efficacy of t h e treatment received by group A and group B was also studied in terms of th e time of "clearin g" to the Note: Some patients had r eceived Goeckerman t herapy on a n ambulatory basis before admission, and were therefore able to tolerate a high er dose of ultraviolet radiation. This accounts for cumu lative doses of ultrav iolet radiation being high er for som e individuals within a given skin type than th ose starting at t h e dose levels indicated in T able III. time of exacerbation. This was determined by either the physician's evaluation that the psoriasis was worsening or if necessary by telephone contact. The 18 mo data concerning exacerbation indicate that the 2 groups are similar except for an apparently initial higher number of failures at 1 mo in group B.
Cumula tive Pa ti e nt s Rehospitalize d In E ach Group
This difference, however, is not statistically significant (p > 0.25).
DISCUSSION
Goeckerman first described the use of crude coal tar and ultraviolet light for the successful treatment of psoriasis 55 yl' ago. Its efficacy has been documented repeatedly in routine hospital care. However, there has been considerable debate concerning the relative therapeutic necessity and importance of tar as well as the type and amount of ultraviolet radiation (Table VII) . It is only recently that quantitative dosimetry of the ultraviolet light administered [13, 15] has been included in studies of Goeckerman therapy. Unfortunately evaluation of the length of remission obtained by any of these modifications of the Goeckerman regimen has rarely been reported [2, 20] .
Quantitative ultraviolet light dosimetry was used in comparing the therapeutic response of patients in group A and group B. The ambulatory component of the hospital Goeckerman regimen was investigated and analyzed statistically using matched pairs. Its efficacy was found to be comparable to that for most patients who were hospitalized for 3 weeks (group A).
Although paiTed comparisons of tar gel and crude tar ointment were not pelformed in this study, the therapeutic data obtained with the tar gel correlated closely with that obtained by Perry, Soderstrom, and Schulze [2] using crude coal tar when assessed in terms of rate of improvement during the period of hospitalization and time required for clearing. The average hospitalization of 20 days in this study is strikingly similar to the findings reported at the Mayo Clinic 12 y r ago. Those patients who were in our study had greater than 25% of body surface involvement and obtained at least 80% clearing. In those patients described by Perry, Soderstrom, and Schulze with similar extent and resolution of psoriasis the average hospital stay was 19-21 days. Mac K enna [19] in 1959 also reported an average length of hospital stay of 21 days for patients receiving crude coal tar for Goeckerman therapy. The similar dW'ation of hospitalization of these 3 studies also suggest that the effectiveness of the tar gel is comparable to crude tar ointments. In terms of treatment compliance, especiaUy for use at home, the tar gel is clearly preferred by patients. Other investigators have also found that tar gel is effective, but report that more phototherapy treatments are necessary for clearing t han with crude tar ointment [11 ,14,15] ' A major difficulty in comparing length of hospitalization in this study with other published series arises from ambiguity abo ut the number of phototherapy treatments [14, 16] . D ays when treatments were deferred because of tenderness or eryt hema were not recorded in most studies.
Data concerning type and amount of total ultraviolet radiation received is as relevant in determining actual effect of Goeckerman therapy as the number of phototherapy treatments. With the increased use of dosimetry and standardization of meters becoming more prevalent, compaTisons of the therapeu tic results of different studies as well as the long-term effects of Goeckerman phototherapy will become more meaningful. However, until a standard technique and instrument for calibrating phototherapy units has been accepted, dosimetry will remain a problem [15] . In a recent study of modified Goeckerman therapy suberythema doses were reported by Frost et al [15] . His schedule of UVB required 25-30 treatments for clearing of most psoriatic lesions with a mean cumulative dose of UVE of 406 mJ/ sq cm, where daily erythema was not attained. However, direct comparison of these data with our results is not possible since different meters and ftlters were used. The minimal erythema dose from UVB reported by Frost was 6-25 mJ /sq cm as compared to our value of 20-50mJ/sq cm in Caucasian patients.
Parrish et al [13] recorded UVB MED's from UVB radiation as 20-45 mJ/ sq em , measuring the irradiance with a patient standing in the phototherapy unit. These minimal erythema doses were similar to ours, but our irradiance was measured with the sensor in an empty phototherapy unit. Using similar treatment schedules, Parrish's recorded cumulative UVB dose (657-3950 mJ / sq cm) is also less than ours. This may be explained by dosimetry studies that indicate 10-20% higher recorded levels of UVB when irradiance measurements are made in a n empty chamber rather than with an enclosed patient who is absorbing photons. To date no ideal system is available that measures the amount of photons absorbed by the patient.
By quantitating UVB exposure to UVB dosimetry allows comparison of one possible variable in the Goeckerman therapy. In this study, the insignificant difference in the 2 groups' cumulative doses of UVB eliminates total UVB exposure as a variable factor of the time and rate of progress in group A and group B .
The amount of time that improvement is maintained following "clearing" is an important consideration in assessing the value of that therapy. The endpoint of remission for a nyone patient is determined bot h by t he increase of the number a nd size of psoriatic lesions and the patient's impression t hat his disease has reached an unacceptable stage. Quantitating these clinical ftndings for comparison of the status of all patients is difficult and involved subjective factors.
The use of matched pairs in this study permitted statistical comparison of 2 groups. It permitted the control of the major variables of patient populations related to: age, sex, and season of therapy thus assuring similarity of the groups. To t he best of our knowledge this paper documents for the first time that the response of a group receiving part of the treatment on an ambulatory basis is not statistically different from the group treated entiTely in t he hospital. Two parameters were followed for this compa rison: (1) the length oftime until a n exacerbation of psoriasis was noted, a nd (2) the proportion of patients whose exacerbation was sufficient to require readmission. To date the course of patients in this matched pail' study is comparable for both groups using the two criteria individually 01' together. These preliminary data suggest that a portion of inpatient Goeckerman therapy ca n be a dministered partially in an ambulatory care setting without altering t he rate of improvement 01' the time 'required for "cleaTing."
European studies had first indicated the feasibility of this approach [25] . Cram and King [22, 26] described the first day care center for psoriasis to the United States. His studies suggested an ambulatory center would be a less expensive method of treating psoriatic patients with hospital level care than would full inpatient hospitalization. The possibilities of using a total a mbulatory care Goeckerman regimen needs to be further evaluated a nd compared to group A and group B. Our initial data suggests a significantly longer period of time is required for clearing a nd that the rate of improvement is slower in the program described by Cram .
It is also important to have further controlled studies with lower doses of ultraviolet light, shorter periods of hospitalization and more esthetic topical tar preparations. Throughout all the proposed studies the goals should remain to increase the rate of clearing of psoriasis and decrease the hospital stay. A prolonged length of remission must also be sought. None of the 3 goals should be compromised for expediency.
This report is not intended to be definitive, but rather to present the eal'ly findings of a prospective study of Goeckerman therapy. A. larger investigation of 75 matched pail's, each observed for two yeal'S, is cWTently in progress.
In summaTY, this study has shown the feasibility of using a n esthetic tal' preparation and quantitative amounts of ultraviolet A and B (based on skin types) in the administration of a modified Goeckerman regimen. Matched pail' studies indicate that patients receiving t his type of th era py showed the same degree a nd rate of improvement and m ai ntena nce of clearing when the last t hird of hospital treatmen t was delivered in a n ambulatory day care psoriasis center.
